Immix Biopharma annual free cash flow
2021
2023
2024
2025
Immix Biopharma Free Cash Flow (FCF) History (IMMX)
Immix Biopharma reported −$24.7M in free cash flow for fiscal 2025, a decrease of $8.9M from the previous fiscal year.
View full Immix Biopharma company overviewImmix Biopharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$24.7M | −$8.9M | — | — |
| 2024 | 2024-12-31 | −$15.8M | −$4.3M | — | — |
| 2023 | 2023-12-31 | −$11.4M | −$9.8M | — | — |
| 2021 | 2021-12-31 | −$1.6M | — | — | — |
Immix Biopharma quarterly free cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$11.8M | −$6.3M | — | — |
| Q1 2026 | 2026-03-31 | −$9.9M | −$8.1M | — | — |
| Q4 2025 | 2025-12-31 | −$11.2M | −$9.2M | — | — |
| Q3 2025 | 2025-09-30 | −$6.3M | −$2.0M | — | — |
| Q2 2025 | 2025-06-30 | −$5.4M | −$84,366 | — | — |
| Q1 2025 | 2025-03-31 | −$1.8M | $2.4M | — | — |
| Q4 2024 | 2024-12-31 | −$2.0M | −$869,255 | — | — |
| Q3 2024 | 2024-09-30 | −$4.3M | −$4.3M | — | — |
| Q2 2024 | 2024-06-30 | −$5.4M | −$5.2M | — | — |
| Q1 2024 | 2024-03-31 | −$4.1M | −$3.9M | — | — |
| Q4 2021 | 2021-12-31 | −$1.1M | — | — | — |
| Q3 2021 | 2021-09-30 | −$50,759 | — | — | — |
| Q2 2021 | 2021-06-30 | −$158,008 | — | — | — |
| Q1 2021 | 2021-03-31 | −$267,248 | — | — | — |
Immix Biopharma free cash flow growth trends
Immix Biopharma's latest reported quarter, Q2 2026, generated −$11.8M in free cash flow, a decrease of $6.3M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Immix Biopharma filings at SEC.gov ↗